Back to top
more

Cardinal Health (CAH)

(Real Time Quote from BATS)

$99.10 USD

99.10
524,266

+0.40 (0.41%)

Updated May 17, 2024 02:04 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (146 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

McKesson (MCK) to Report Q2 Earnings: What's in the Offing?

McKesson's (MCK) Pharmaceutical and Specialty Solutions unit is expected to have driven its fiscal Q2 results.

Can Global Industrial Unit Drive Ecolab's (ECL) Q3 Earnings?

Positive developments in the Global Industrial unit are expected to have driven Ecolab's (ECL) Q3 results.

Is Deep Value ETF (DVP) a Strong ETF Right Now?

Smart Beta ETF report for DVP

Q3 Earnings Reports to Flood Wall Street This Week

Q3 Earnings Reports to Flood Wall Street This Week

Mark Vickery headshot

Opioid Settlement, Boeing Downgrades: Markets Looking Up

Futures are up somewhat in this Monday's pre-market after a sell-off Friday. Much of the sentiment going forward will rely on Q3 results and other news items.

Cerner (CERN) to Report Q3 Earnings: What's in the Offing?

Top-line growth, expected increase in bookings and solid show by Population Health, Revenue Cycle and IT Works are anticipated to get reflected in Cerner's (CERN) Q3 earnings.

What's in the Offing for Baxter's (BAX) Earnings in Q3?

Baxter's (BAX) Q3 earnings is likely to have benefited from better-than-expected performance at Acute Therapies segment, solid product portfolio and anticipated rise in revenues.

What's in Store for Varian Medical (VAR) in Q4 Earnings?

Varian (VAR) is expected to have gained from core Proton Therapy platform in fiscal Q4.

What's in Store for Intuitive Surgical (ISRG) in Q3 Earnings?

Better-than-expected performance at Instruments & Accessories segment and da Vinci procedure growth are likely to aided Intuitive Surgical (ISRG) in Q3 earnings.

Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Sreyoshi Mukherjee headshot

Dental Supplies Industry's Near-Term Outlook Looks Bright

With popular trends of digital dentistry and robotics gaining momentum, near-term prospects of the dental industry look promising.

Here's Why You Should Retain Cardinal Health Stock for Now

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.

The Zacks Analyst Blog Highlights: Apple, Exxon, AT&T, Cardinal and ANSYS

The Zacks Analyst Blog Highlights: Apple, Exxon, AT&T, Cardinal and ANSYS

Mark Vickery headshot

Top Stock Reports for Apple, Exxon Mobil & AT&T

. Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Exxon Mobil (XOM) and AT&T (T).

Why Is Cardinal (CAH) Up 3.5% Since Last Earnings Report?

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Hold on to Cardinal Health (CAH) Stock

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.

Can Value Investors Consider Cardinal Health (CAH) Stock?

Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.

Company News For Aug 9, 2019

Companies in the news are: CAH, KTB, NCLH and VIAB

Cardinal Health (CAH) Q4 Earnings and Revenues Top Estimates

Cardinal Health (CAH) Q4 results benefit from strong performance by Pharmaceutical segment and higher revenues. However, contraction in gross margin remains a concern.

Cardinal Health (CAH) Q4 Earnings and Revenues Beat Estimates

Cardinal (CAH) delivered earnings and revenue surprises of 19.35% and 1.24%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Cardinal Health (CAH) in Q4 Earnings?

Better-than-expected performance at Pharmaceutical and Medical segments are likely to aid Cardinal Health's (CAH) in Q4 earnings.

Analysts Estimate Cardinal Health (CAH) to Report a Decline in Earnings: What to Look Out for

Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured highlights include: Cardinal Health, Builders FirstSource, AmerisourceBergen, AutoNation and Party City

Zacks.com featured highlights include: Cardinal Health, Builders FirstSource, AmerisourceBergen, AutoNation and Party City

Maharathi Basu headshot

Recent Analyst Upgrades Add Shine to These 5 Stocks

The opinion of brokers is highly valued by investors as they have a clear insight into the nitty gritty of the investment world.

Zacks.com featured highlights include: Antero Resources, Avis Budget, NOW, Cardinal Health and Asbury Automotive

Zacks.com featured highlights include: Antero Resources, Avis Budget, NOW, Cardinal Health and Asbury Automotive